US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

3.1600
+0.0600+1.94%

Close Feb 14 16:00 ET

3.0903
-0.0697-2.21%

Post 19:09 ET

3.81MMarket Cap-0.25P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	1.601M / 2.005M	--
--	2024/Q2	1.682M / 1.518M	--
--	2024/Q1	1.243M / 1.895M	--
--	2023/Q4	3.126M / 3.039M	--
Sep 23, 2022	2022/Q4	698.290K / 969.890K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q31.601M / 2.005M--

--2024/Q21.682M / 1.518M--

--2024/Q11.243M / 1.895M--

--2023/Q43.126M / 3.039M--

Sep 23, 20222022/Q4698.290K / 969.890K--

Unlock Free Earnings Estimates

Open Account

InMed Pharmaceuticals Earnings Reports

InMed Pharmaceuticals | 8-K: InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

Feb 13 09:39 ET

InMed Pharmaceuticals | 10-Q: Quarterly report

Feb 12 17:36 ET

InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

Nov 15, 2024 11:28 ET

InMed Pharmaceuticals | 10-Q: Q1 2025 Earnings Report

Nov 14, 2024 16:22 ET